The change in ownership is noted in a single sentence on the “About” page on Throtle’s website: “Throtle Inc. is a wholly owned subsidiary of IQVIA Inc., operating as an independent unit within IQVIA ...

Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides healthcare research services. Valued at $37.6 billion by ...

BARCELONA, Spain--(BUSINESS WIRE)--IQVIA (NYSE: IQV), a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the ...

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today launched two new capabilities to support clinical teams more easily and quickly share cross-trial training ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

As clinical research evolves, integrated technologies are reshaping patient and site experiences through AI, remote monitoring, and next-generation telehealth. Join IQVIA experts Chris Driver and Dan ...

New multiyear collaboration between Florence Healthcare and IQVIA to ensure research sites participating in IQVIA studies have access to best-in-class site enablement technology to streamline ...

Nov 1 (Reuters) - IQVIA Holdings (IQV.N), opens new tab cut its full-year profit forecast on Wednesday, citing weakness in demand for its analytics and medical technology solutions along with the ...

IQVIA Holdings Inc. IQV yesterday unveiled a clinical trial technology platform, One Home for Sites. The platform streamlines the process of management of trials by acting as a single sign-on and a ...

Bold initiative to boost the capacity of research sites enters Beta testing and piloting RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV) today announced the launch of One Home for ...

IQVIA Holdings has recently seen its consensus analyst price target rise significantly, climbing from $223.42 to $246.84.